ask="N/A"
ask_size="N/A"
average_daily_volume="5420"
bid="0.3000"
bid_size="5000"
book_value="0.0000"
change="+0.0198"
change_from_200_day_moving_average="-0.3119"
change_from_50_day_moving_average="0.0086"
change_from_52_week_high="-1.4902"
change_From_52_week_low="0.2884"
change_in_percent="+5.0769%"
close="0.4098"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="N/A"
ebitda="0.00"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="N/A"
ex_dividend_date="N/A"
float_shares="N/A"
high="0.4200"
high_52_weeks="1.9000"
last_trade_date="3/16/2017"
last_trade_price="0.4098"
last_trade_size="100"
last_trade_time="10:53am"
low="0.4098"
low_52_weeks="0.1214"
market_capitalization="N/A"
moving_average_200_day="0.7217"
moving_average_50_day="0.4012"
name="Oncobiologics
Inc."
notes="N/A"
one_year_target_price="N/A"
open="0.4200"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-43.2185%"
percent_change_from_50_day_moving_average="+2.1545%"
percent_change_from_52_week_high="-78.4316%"
percent_change_from_52_week_low="+237.5618%"
previous_close="0.3900"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="N/A"
short_ratio="0.0000"
stock_exchange="NGM"
symbol="ONSIZ"
volume="1000"
weeks_range_52="0.1214 - 1.9000"
